Arici et al. (2003) found measurable levels of IL-18 in the peritoneal fluid of patients receiving GnRH agonists for endometriosis to be significantly higher than those of the control group—patients with endometriosis without treatment [40]. This evidence concerns the gene GNRH1 and endometriosis.